Drug
Al001
Al001: highest development phase Phase 1/2, developed by Alzamend Neuro, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Alzamend Neuro, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| AL001 NCT07540338 | Phase 1/2 | Bipolar I Disorder |
Latest
No recent events.
Follow Al001 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.